VRDN
Viridian Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $10.0M of Viridian Therapeutics, Inc.
10% owner
Bought$9,999,990
$21.00Price
476,190Shares
+35%Stake
What VRDN did for a copier
- $1,000 copied at Thu, Jan 25 open, $19.77
- $968
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Mar 8 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −7.6% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Jan 22. Filed Wed, Jan 24. Returns use the Jan 25 open and the Mar 8 close. Not investment advice.